IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND STATINS IN RHYTHM CONTROL STRATEGY OF ATRIAL FIBRILLATION

被引：0
|
作者：
Providencia, R. [1 ]
Botelho, A. [1 ]
Silva, J. [1 ]
Seca, L. [1 ]
Gomes, P. L. [1 ]
Barra, S. [1 ]
Quintal, N. [1 ]
Nascimento, J. [1 ]
Leitao-Marques, A. M. [1 ]
机构：
[1] Coimbras Hosp Ctr, Dept Cardiol, Coimbra, Portugal
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000378362.68434.a7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [41] Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?
    Savelieva, Irina
    Camm, John
    AMERICAN HEART JOURNAL, 2007, 154 (03) : 403 - 406
  • [42] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation
    Zheng, Bin
    Kang, Junping
    Tian, Ying
    Tang, Ribo
    Long, Deyong
    Yu, Ronghui
    He, Hua
    Zhang, Ming
    Shi, Lisheng
    Tao, Hailong
    Liu, Xingpeng
    Dong, Jianzeng
    Ma, Changsheng
    ACTA CARDIOLOGICA, 2009, 64 (03) : 335 - 340
  • [43] Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: potential benefits for the prevention of atrial fibrillation: reply
    Yin, Yuehui
    Dalal, Darshan
    Dong, Jun
    EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2371 - 2371
  • [44] Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the mortality in sepsis: A meta-analysis
    Yang, Deng-Can
    Xu, Jian
    Jian, Li
    Yu, Yi
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (36)
  • [45] The Impact of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with Clostridium difficile infection
    Patel, Shilpa M.
    Stashefsky, Evan
    Maroun, Marie-Claire
    Johnson, Leonard B.
    MEDICAL HYPOTHESES, 2011, 76 (06) : 813 - 815
  • [46] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
  • [47] In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1553 - 1556
  • [48] Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators
    Lai, Hoang M.
    Aronow, Wilbert S.
    Kruger, Adam
    Desai, Harit
    Amin, Harshad
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (01): : 77 - 78
  • [49] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [50] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
12345